Cancer research and treatment is something that is very personal to Graham Hefelfinger, a 9th grade student at Chaminade High School. He recently lost his godcousin, Bailey Buell, to a rare cancer ...

University of Phoenix is proud to announce the release of four new episodes of the Degrees of Success™ podcast which showcases the inspiring journeys ...

Five-year data shows lasting benefit for patients with advanced gastroesophageal cancers treated with nivolumab and chemotherapy.

Among patients with advanced gastric and GEJ cancer, or esophageal adenocarcinoma, treatment with first-line Opdivo and chemo demonstrated deep responses.

Radon levels tend to be highest during the colder months, when doors and windows stay closed. People in most Pennsylvania counties, including the Philly suburbs, are particularly at risk.

CheckMate 649 trial showed sustained efficacy with frontline nivolumab plus chemotherapy vs chemotherapy alone in patients with gastric cancers.

CMS evaluates hospitals using 10 HCAHPS star ratings, one of which is the patient's response to the critical question "Would you recommend this hospital to your friends and family?" To qualify for a s ...

Workers at MultiCare Yakima Memorial Hospital voted overwhelmingly to join Teamsters Local 760. The new Teamsters work as ...

Exploring the combination with azacitidineStudy led by Medical College of Wisconsin MADRID and CAMBRIDGE, Mass., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY) ...

These data are consistent with previous GPS trials. In the Phase 2 study in AML patients in second complete remission, the median overall survival of GPS-treated patients was 21 months versus 5.4 ...

Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today ...